
Published: 1 year ago
Size: 29.4MB
In this CME activity, an expert in the management of age-related macular degeneration discusses recent data on the incorporation of anti-VEGF agents鈥攅ither alone or in combination鈥攊nto treatment regimens.
unknown filetype: pdf
Published: 1 year ago
Size: 86.0KB
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file.

Published: 2 years ago
Size: 32.6MB
In this CME activity, experts in the treatment of diabetes and diabetic retinopathy present recent data on the efficacy of emerging agents used in the treatment of diabetic macular edema. The molecular mechanisms for the development of this condition are reviewed. Recent updates in the management of diabetes are highlighted.
unknown filetype: pdf
Published: 2 years ago
Size: 291.4KB
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file.

Published: 2 years ago
Size: 22.3MB
In this activity, experts in the treatment of age-related macular degeneration (AMD) present current data on the efficacy and safety of anti-VEGF agents used in the treatment of the wet form of this condition. Strategies for incorporating anti-VEGF agents into the management plan are also discussed.